chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of MULTISYSTEM INFLAMMATORY SYNDROME (multiple inflammatory syndrome) and NEURALGIA (nerve pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A, 032M20A and 049E21A) for COVID-19 vaccination. The patient's past medical history included Chronic fatigue syndrome since an unknown date and Fibromyalgia since an unknown date. Concurrent medical conditions included Drug allergy (erythromycin). On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MULTISYSTEM INFLAMMATORY SYNDROME (multiple inflammatory syndrome) and NEURALGIA (nerve pain). At the time of the report, MULTISYSTEM INFLAMMATORY SYNDROME (multiple inflammatory syndrome) and NEURALGIA (nerve pain) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal. On an unknown date, Electrocardiogram: normal (normal) normal. No concomitant medication provided. No treatment information mentioned. Patient described pain happening all the time and affected her daily routine functions. patient said has visited HCP and steroid shot was given. caller had HCP visit coming up. Caller contact information was confirmed. Consent for safety follow up was accepted.
The pt experienced uncontrolled sobbing and then slowed to gasping. Mom called 911. Episodes began approximately 24 hours post vax. The MD feels the infant was upset, holding breath. The pt passed her physical and the physician does not feel it was vaccine related. Pt was fine by the time the EMT's arrived, laughing and cooing.
Heart palpatations. I've never had this feeling ever.; This is a spontaneous report from a contactable Consumer. This 55-year-old male consumer (patient) reported that.  A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 15Aug2021 14:30 as (At the age of 55-years) dose 1, single for covid-19 immunisation. Medical history included Slight Asthma, Outdoor Allergies, Slight chronic obstructive pulmonary disease (COPD), Swelling of the legs and ankles from an unknown date and unknown if ongoing. Other medications in two weeks: Metformin, levothyroxine sodium (SYNTHROID), fexofenadine hydrochloride (ALLEGRA), Mens Multi-Vitamin taken for an unspecified indication, start and stop date were not reported.The patient previously  Laundry detergent and experienced dermatitis contact Known allergies of  Laundry detergent. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient experienced heart palpatations. i've never had this feeling ever on 17Aug2021 04:00. Patient did not receive any treatment for event. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
The child developed bronchospastic cough approximately 45 minutes after immunization. On lung exam, she had diffuse wheezing which was not present on initial exam. She was treated with Prelone and given three Albuterol nebulizer treatments. After which she had minimal wheezing. Then approximately 2 hours later the patient developed persistent cough and diffuse wheezing on exam. Therefore was sent to the ER for further management.
Redness starting at the injection site / Down the arm; Confusion; Feeling faint / Dizzy; Tired; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 18th October 2020, 3 days after receiving Shingrix, the patient experienced injection site erythema, confusion, felt faint and tiredness. On an unknown date, the outcome of the injection site erythema and felt faint were not recovered/not resolved and the outcome of the confusion and tiredness were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, confusion, felt faint and tiredness to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient experienced confusion, feeling faint, tired, and dizzy.   The patient also experianced redness starting at the injection site, and travelling about 6 inches down the arm. The reporter consented to follow up.
Patient reports getting the Bivalent booster vaccine at pharmacy on Thursday evening, 9/15/22. He reports waking up on Friday morning, 9/16/22 with several small blisters to his left upper eyelid. He reports associated pain and itching, no drainage. His eyelid has become swollen as well.
On 9/13/2021 noticed the posterior aspect of my right shoulder, behind the deltoid was sore and there was a quarter-sized bump and a localized skin reaction where the shot was given.  11/10/2021 Quarter-sized lump is gone as well as skin reaction, but pain in the right arm is still very much present.
Patient received her second Moderna Vaccine last night and moved during administration. The nurse had injected part of the vaccine, the patient moved and the needle grazed the patients skin.  The vaccine was visible by mom on the patient's skin.  The nurse then punctured the skin a second time and injected the rest of the vaccine.
Severe joint pain, muscle pain, nausea, chills, cold sweats, wracking headache, lasting 12 + hours
I got the first shot but got shingles before I got the booster/suspected Vaccination failure; I have shingles right now.; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 19-APR-2022  Reporter's Comments: This case was received from the patient via interactive digital media. The patient got the first shot but got shingles before he/she got the booster. The patient had shingles right now. The patient advised to definitely get the booster as soon as recommended. Additional Supportive Information: This case described the occurrence of suspected vaccination failure. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Head feels heavy; Nose feels weird; the muscle on the left arm there's pain; 50 days apart between 1st and 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Head feels heavy), NASAL DISCOMFORT (Nose feels weird), PAIN IN EXTREMITY (the muscle on the left arm there's pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days apart between 1st and 2nd dose) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days apart between 1st and 2nd dose). On an unknown date, the patient experienced HEAD DISCOMFORT (Head feels heavy), NASAL DISCOMFORT (Nose feels weird) and PAIN IN EXTREMITY (the muscle on the left arm there's pain). On 20-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days apart between 1st and 2nd dose) had resolved. At the time of the report, HEAD DISCOMFORT (Head feels heavy), NASAL DISCOMFORT (Nose feels weird) and PAIN IN EXTREMITY (the muscle on the left arm there's pain) had not resolved.            No concomitant medications were reported. The patient had been experienced some medical issues after vaccination. Outcome of the events were reported as still ongoing. No treatment medications were reported.
This spontaneous report as received from a physician refers to multiple unspecified patients of unknown age. On an unknown date the patient was vaccinated with doses of improperly stored VAQTA (unknown lot #s and expiration dates). The vaccine was stored under 1.3 degree Celsius for 35 hours. No previous temperature excursion. No adverse effect was reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Body aches, fever, body rashes severe. Fever w/ rigors. Did not measure temp. Diarrhea at evening of 4/5/14. Sore arm - entire upper arm to elbow swollen and warm to touch.
Acute onset Autoimmune hemolytic anemia requiring IV steroids and hospitalization.Records received 4/24/07-from facility for DOS 02/13-02/15/07- DC DX: warm agglutinin autoimmune hemolytic anemia. Found at routine visit to be anemic by PCP.  RX with high dose steroids. Two week HX of fatigue pallor, nauseated. 4-6 weeks prior had URI .
Developed itchy hives all over body, have continued for 10 days thus far. Raised red welts occur wherever clothing rubs, I scratch or I rub. I have no history of hives unless I have peanuts, in which case the hives last only a few hours. Called PCP 12/16/2021. Prescribed prednisone taper. No office visit available. Took prednisone taper plus Benadryl to manage symptoms. Had appointment with dermatologist on 12/21/2021, she could not determine cause for hives. Prescribed additional topical steroid. Recommended Zyrtec. Responding well to medication. Hives worst in morning and evenings when medicine has worn off.
A few days after receiving the first Pfizer Covid 19 vaccine I have an insidious mark running down my right forearm.  I initially thought it was a bruise but don't recall hitting my arm in such a violent way to create this big purple mark on my arm.  After weeks-the mark is still there and is not fading.  I've also been getting short flashes of headaches that I don't recall experiencing in the past.
Two days post vax, pt woke up in the am with swollen fingers, hands and upper arms. The middle knuckle on my right hand is swollen more than the rest. This is the first vax that pt ever had. Treatment given Viox and Relafen. Pt couldn't grip things or move her arm, my fingers start to tingle when I grip a pencil or take a shower.
She said her husband had experienced Fever; Chills; Diarrhea; This is a spontaneous report from a sponsored program Support. A contactable consumer (wife) reported for a male patient (husband).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The caller was calling on behalf of her husband. She said her husband had experienced fever, chills and diarrhea on an unspecified date, after receiving the first shot of Covid-19 Vaccine. She was asking 2 weeks after receiving the first shot side effects occur. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected. Information about lot/batch number requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
No adverse event; First dose  12-MAR-2021 and Second dose  29-MAR-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose  12-MAR-2021 and Second dose  29-MAR-2021) and NO ADVERSE EVENT (No adverse event) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had no known allergies.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose  12-MAR-2021 and Second dose  29-MAR-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose  12-MAR-2021 and Second dose  29-MAR-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No concomitant medications were provided by the reporter. No treatment information were provided.   This case was linked to MOD-2022-627608 (Patient Link).
Had IZs 6/9/09, on 6/11/09 MOC called, stated pt. had red area back of rt. arm, size 1"x2", hurts a little, not itchy
Information has been received from a certified medical assistant concerning a less than 18 month old male who on 05-OCT-2007 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine instead of PREVNAR. There was no adverse event reported. No product quality complaint was involved. Additional information has been requested.
Day following administration of vaccine shot, I developed shingles virus. I have had Zoster vaccinations against shingles in 2008, 2018, and 2019 (recombinant). The shingles rash started March 13. The rash became open sores about a week later. I was seen by my primary care physician's office on March 12 and was given a prescription of empiric valtrex.   On April 9, I developed acute pain from muscle stiffness in upper left back next to left shoulder blade. On July 30, I developed acute pain from muscle stiffness in upper right back next to right shoulder blade. These stiffnesses are unusual for me. both cases required treatment of Flexeril to relax the muscles.
Rash on back, head and hands evening after receiving H1N1 vaccine - Took BENADRYL - rash resolved within 24 hrs.
Post vax, the pt developed swelling, redness, and tenderness at injection site. Pain was severe enough to cause limited range of motion. She then developed 104 temperature and night sweats. She had taken Tylenol for pain and fever.
While working-out on 6/7/2021 around 8 pm the left-side of my mouth started feeling numb shortly after my left arm started feeling numb and tingly. A slight improvement happened after a few minutes but then it came back on again. I had my wife drive me to the hospital, which is about 20 minutes away. Shortly after the check-in process, the numbness started to fade away. By the time I was seen by a doctor all numbness was gone. They ran the follow test all showing no signs of any issues. CT scan, EKG, bilateral carotid ultrasound, MRI brain, Holter monitor 24 hours, echocardiogram, bubble study and all blood work, diagnoses determined to be a TIA.
A patient took the first capsule of Vivotif on 07/01/2005.  On 06/30/2005 he received Hepatitis A, Di-Te and polio immunization.  Following intake of the second and third Vivotif capsule he developed joint pain, swelling of arms and hands and itchy fingers.
Member received bivalent covid booster on 10/14/2022 and was found unresponsive on 10/15 at 1155, CPR was initiated and member was transfered to the hospital, where she expired.
Lump located on left arm, small redden lump, no pain at site or soreness, seen in PC advised to return if not well in 2 wks. Pt did not return.
This prospective pregnancy case was reported by healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 27-year-old female subject who was vaccinated with CERVARIX, (GlaxoSmithKline). The subject's past medical history included 2 previous pregnancies (1 pre-term (still birth) and 1 full-term (normal birth)). Historic medications included (Low dose minipill) ORTHO MICRONOR for contraception and concurrent medications included Pre-natal vitamins. Examination results included prenatal diagnostic tests on 18 March 2014 (fetal ultrasound). There was no evidence of a defect. On 25 June 2014, the subject received an unspecified dose of CERVARIX (0.5 ml, unknown route, left deltoid). Her last menstrual period as on 1 November 2013 and estimated date of delivery was on 8 August 2014. The subject was exposed to the vaccine at 33 weeks and 5 days gestation. No adverse event was reported. At the time of reporting, the pregnancy was still ongoing. Follow-up received on 16 October 2014: The pregnancy resulted in a live neonate with no apparent congenital anomaly. On 8th October 2014 after 40 weeks, the patient gave birth to a male neonate via vaginal delivery. The neonate weighed 3628 grams (8lbs) at birth. APGAR scores were 7, 8 and 9. The reporter considered the vaccine exposure during pregnancy to be not assessable to CERVARIX.
After Gardasil vaccination client became pale, c/o weakness, diaproic, N/V. BP 120/60. Symptoms abated - BP 102/58. Client was to have Tdap, Gardasil - MCV4 held.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:02/14/21 Pfizer, Lot#EM9810. 2nd dose: 03/06/21 Pfizer, Lot#EN6202. Diagnosed COVID-19 positive:04/13/21. Exposure:Home Symptoms:Runny nose, congestion
This spontaneous report as received from a physician refers to a patient of unknown age. The patient was vaccinated with the first dose of GARDASIL (0.5 ml, route, dose and lot # were unknown) on 09-APR-2012 (also reported on 12-APR-2012), the second on 10-OCT-2012 and the third on 24-OCT-2012. No adverse event reported. Additional information has been requested.
1/7/21: Sore arm the night of the vaccine. 1/8/21: Woke-up around 4am with chills. Fever of 101.4 around 7am with generalized malaise and severe fatigue. Spent most of the day in bed. Fevers on and off throughout the day with Tmax of 101.4.  Some mild body aches. Sore arm with  itching at the injection site. Lump at injection site. Had to call off of work.  Loss of appetite. 1/9/21: Afebrile the whole day. Moderate fatigue in the morning. Overall felt better by the afternoon. Sore arm continued with itching and lump remaining at the injection site. 1/10/21: Overall felt better, arm soreness and itching at injection improving. 1/11/21: Mild fatigue. No arm soreness. Itching improved. Lump at injection site improving. Mild body aches in the evening. 1/12/21: Mild fatigue.  1/13/21: No arm soreness, itching and lump at injection site gone.
Information has been received from a health professional concerning an 8 year old white male with no medical history or allergies who was vaccinated with a dose of varicella virus vaccine live.  On 05/30/2004 the patient experienced an itchy papular rash.  It was reported that it presented 48 hours before office visit.  Medical attention was sought.  Recovery status was unknown.  No additional information is expected.
This spontaneous report was received from a Licensed Practical Nurse regarding a 22 year old female patient. There was no information about concurrent condition and historical medication. On 18-FEB-1993, the patient was vaccinated with first of RECOMBIVAX HB, second dose on 12-MAR-1993 and third dose was given on 19-SEP-1993. There was no information about concomitant medication. On 28-JUL-2015, titers were drawn for immunity to Hepatitis B. The results of the serological testing were negative for Hepatitis B (Hepatitis B surface antibody negative). No product quality complaint (PQC) was involved. Patient was not given treatment for the event. The outcome of serological testing were negative was unknown. Causality between serological testing were negative and RECOMBIVAX HB was unknown. Additional information has been requested.
This case meets criteria for vaccine breakthrough review.  Admitted for abdominal pain.  No respiratory symptoms.
Vaccine expired on 01-Apr-2022, vaccine placed in refigerator on 04-Apr-2022, vaccine administered on 15-Apr-2022; Expired vaccine administered to 155 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, vaccine placed in refigerator on 04-Apr-2022, vaccine administered on 15-Apr-2022) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, vaccine placed in refigerator on 04-Apr-2022, vaccine administered on 15-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, vaccine placed in refigerator on 04-Apr-2022, vaccine administered on 15-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that the pharmacist thought that the expiry date of the vaccine was Jun-2022, However the vaccine expired on 01-Apr-2022. The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo temperature excursion.  No treatment medication was provided.
pt recv ax 2APR96 & seen in ER 6APR96;mom reported pt began a fever of 105 w/in 4-5 hrs p/vax & fever lasted 3 days;pt had a rash that devel late evening on 2APR96;diarrhea & dec appetite;mom told by ER MD pt had allerg rxn to vax;
Large swelling of the left arm, shoulder, pain and itchiness. Warm to the touch
4 hrs p/vax pt became delirious & irritable; no fever; 2 questionable short sz occurred as well; sx lasted approx 24hrs; had normal exam;
Moderna COVID?19 Vaccine EUA  Intense chills and muscle spasms. For approximately 15 minutes I felt cold, and my whole body was shaking. After the cold feeling subsided, the muscles in my legs and lower back locked up and I had to work very hard to get them to relax for several minutes. This event only happened one time and I have felt completely fine since.
severe aggression, hitting parents, hitting strangers. behavior that is completely out of the normal for him.